Published in Int J Mol Sci on March 30, 2012
The future of osteoarthritis therapeutics: emerging biological therapy. Curr Rheumatol Rep (2013) 0.95
The future of osteoarthritis therapeutics: targeted pharmacological therapy. Curr Rheumatol Rep (2013) 0.92
Intersection of inflammation and herbal medicine in the treatment of osteoarthritis. Curr Rheumatol Rep (2012) 0.90
Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study. J Orthop Sci (2014) 0.88
Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Med Food (2016) 0.87
Pathophysiology of osteoarthritis: canonical NF-κB/IKKβ-dependent and kinase-independent effects of IKKα in cartilage degradation and chondrocyte differentiation. RMD Open (2015) 0.83
Resveratrol Interferes with IL1-β-Induced Pro-Inflammatory Paracrine Interaction between Primary Chondrocytes and Macrophages. Nutrients (2016) 0.79
Randomized controlled studies on the efficacy of antiarthritic agents in inhibiting cartilage degeneration and pain associated with progression of osteoarthritis in the rat. Arthritis Res Ther (2016) 0.77
Development and characterization of resveratrol nanoemulsions carrying dual-imaging agents. Ther Deliv (2016) 0.75
Curcumin Inhibits Apoptosis of Chondrocytes through Activation ERK1/2 Signaling Pathways Induced Autophagy. Nutrients (2017) 0.75
Identification of Targets of a New Nutritional Mixture for Osteoarthritis Management Composed by Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract. PLoS One (2016) 0.75
Burden of major musculoskeletal conditions. Bull World Health Organ (2003) 10.89
Demography. Broken limits to life expectancy. Science (2002) 10.65
Role of cytokines in rheumatoid arthritis. Annu Rev Immunol (1996) 10.22
Bioavailability of curcumin: problems and promises. Mol Pharm (2007) 8.72
Human IL-17: a novel cytokine derived from T cells. J Immunol (1995) 6.65
Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res (2003) 5.72
Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature (1986) 5.68
Osteoarthritis. J Cell Physiol (2007) 5.55
Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A (1991) 5.07
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res (2004) 4.69
Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum (1990) 4.39
Curcumin: the Indian solid gold. Adv Exp Med Biol (2007) 4.12
Nuclear factor-kappaB: its role in health and disease. J Mol Med (Berl) (2004) 4.01
Anchorage dependence, integrins, and apoptosis. Cell (1994) 3.96
Resolving inconsistencies in trends in old-age disability: report from a technical working group. Demography (2004) 3.72
Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. J Clin Invest (1998) 3.54
Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature (1977) 3.46
Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect (1998) 3.27
Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev (2009) 3.15
The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol (2010) 3.14
Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol (2000) 2.86
Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus. J Cell Biol (1993) 2.74
A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest (1999) 2.65
The burden of musculoskeletal disease--a global perspective. Clin Rheumatol (2006) 2.59
Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell (2007) 2.51
Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J Biol Chem (1998) 2.43
Osteoarthritis: an overview of the disease and its treatment strategies. Semin Arthritis Rheum (2005) 2.39
Articular cartilage and osteoarthritis. Instr Course Lect (2005) 2.39
Study of 500 patients with limb joint osteoarthritis. I. Analysis by age, sex, and distribution of symptomatic joint sites. Ann Rheum Dis (1991) 2.35
Developments in the scientific understanding of osteoarthritis. Arthritis Res Ther (2009) 2.22
Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol (2006) 2.19
The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res Ther (2006) 1.93
Anti-cytokine therapy for rheumatoid arthritis. Annu Rev Med (2000) 1.90
Articular cartilage: tissue design and chondrocyte-matrix interactions. Instr Course Lect (1998) 1.90
NF-kappaB signaling: multiple angles to target OA. Curr Drug Targets (2010) 1.89
Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem (1998) 1.87
Altered mechanics of cartilage with osteoarthritis: human osteoarthritis and an experimental model of joint degeneration. Osteoarthritis Cartilage (1999) 1.82
Sirtuins: novel targets for metabolic disease. Curr Opin Investig Drugs (2008) 1.80
Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage (2003) 1.79
Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes. Exp Cell Res (2003) 1.79
Neutrophil attractant/activation protein-1 (NAP-1 [interleukin-8]). Am J Respir Cell Mol Biol (1990) 1.76
Impact of osteoarthritis on individuals and society: how much disability? Social consequences and health economic implications. Curr Opin Rheumatol (2002) 1.74
Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J Med Res (1980) 1.74
Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. Biochem Pharmacol (2007) 1.73
Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun (1993) 1.73
The pericellular matrix as a transducer of biomechanical and biochemical signals in articular cartilage. Ann N Y Acad Sci (2006) 1.71
Cytokines and their role in the pathophysiology of osteoarthritis. Front Biosci (1999) 1.67
Athletics and osteoarthritis. Am J Sports Med (1998) 1.65
Comparison between chondroprotective effects of glucosamine, curcumin, and diacerein in IL-1beta-stimulated C-28/I2 chondrocytes. Osteoarthritis Cartilage (2008) 1.62
Human, rat, and mouse metabolism of resveratrol. Pharm Res (2002) 1.62
Structure and function of aggrecan. Cell Res (2002) 1.62
Age-related changes in the morphology and deformational behavior of knee joint cartilage. Arthritis Rheum (2001) 1.58
Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis. Arthritis Res Ther (2009) 1.56
The role of tumor necrosis factor in health and disease. J Rheumatol Suppl (1999) 1.54
An introduction to the pathophysiology of osteoarthritis. Front Biosci (1999) 1.54
Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes. Arthritis Rheum (2001) 1.53
Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro. Biochem Pharmacol (2007) 1.51
The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules. Bioessays (1995) 1.51
Differential effects of bFGF and IGF-I on matrix metabolism in calf and adult bovine cartilage explants. Arch Biochem Biophys (1994) 1.49
Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann N Y Acad Sci (2004) 1.49
Wine as a biological fluid: history, production, and role in disease prevention. J Clin Lab Anal (1997) 1.48
Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis. J Immunol (2000) 1.45
Epidemiology of osteoarthritis: an update. Curr Opin Rheumatol (2006) 1.45
Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions. Cancer (2006) 1.45
Articular cartilage repair. Am J Sports Med (1998) 1.42
Natural products as targeted modulators of the nuclear factor-kappaB pathway. J Pharm Pharmacol (2002) 1.40
Why is osteoarthritis an age-related disease? Best Pract Res Clin Rheumatol (2010) 1.40
Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem (2000) 1.38
Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem Pharmacol (2008) 1.37
Integrin-dependent signal cascades in chondrocyte mechanotransduction. Ann Biomed Eng (2004) 1.37
IL-8/CXCL8 and growth-related oncogene alpha/CXCL1 induce chondrocyte hypertrophic differentiation. J Immunol (2003) 1.36
Comparison of Anti-inflammatory Activities of Six Curcuma Rhizomes: A Possible Curcuminoid-independent Pathway Mediated by Curcuma phaeocaulis Extract. Evid Based Complement Alternat Med (2006) 1.35
Effects of resveratrol in inflammatory arthritis. Inflammation (2007) 1.34
The relationship between disease symptoms, life events, coping and treatment, and depression among older adults with osteoarthritis. J Rheumatol (2008) 1.32
Aging and osteoarthritis. Curr Opin Rheumatol (2011) 1.31
Aggrecan, aging and assembly in articular cartilage. Cell Mol Life Sci (2005) 1.31
Collagens and cartilage matrix homeostasis. Clin Orthop Relat Res (2004) 1.30
Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. J Nat Prod (2006) 1.30
Stimulation of in vitro somite chondrogenesis by procollagen and collagen. Nature (1975) 1.30
Modulation of transcription factors by curcumin. Adv Exp Med Biol (2007) 1.30
Cartilage proteoglycans: structure and potential functions. Microsc Res Tech (1994) 1.28
From exotic spice to modern drug? Cell (2007) 1.27
Risk factors for osteoarthritis: understanding joint vulnerability. Clin Orthop Relat Res (2004) 1.26
Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J Infect Dis (1995) 1.26
Integrins and stretch activated ion channels; putative components of functional cell surface mechanoreceptors in articular chondrocytes. Cell Biol Int (2002) 1.25
Effect of resveratrol in experimental osteoarthritis in rabbits. Inflamm Res (2005) 1.24
NF-kappaB: a potential target for cancer chemoprevention and therapy. Front Biosci (2008) 1.24
The joint capsule: structure, composition, ageing and disease. J Anat (1994) 1.23
Biomarkers in osteoarthritis. Curr Opin Rheumatol (2003) 1.22
TNFalpha suppresses link protein and type II collagen expression in chondrocytes: Role of MEK1/2 and NF-kappaB signaling pathways. J Cell Physiol (2003) 1.22
Post-traumatic osteoarthritis: the role of accelerated chondrocyte senescence. Biorheology (2004) 1.22
Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts. Osteoarthritis Cartilage (2005) 1.22
In vivo morphometry and functional analysis of human articular cartilage with quantitative magnetic resonance imaging--from image to data, from data to theory. Anat Embryol (Berl) (2001) 1.21
Synovial joint degeneration and the syndrome of osteoarthritis. Instr Course Lect (2000) 1.21
Biomarker discovery and validation: technologies and integrative approaches. Trends Biotechnol (2004) 1.20
The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflamm Res (2006) 1.18
Aging theories of primary osteoarthritis: from epidemiology to molecular biology. Rejuvenation Res (2004) 1.18
In vivo effects of interleukin-1 on articular cartilage. Prolongation of proteoglycan metabolic disturbances in old mice. Arthritis Rheum (1991) 1.18
Biological actions of curcumin on articular chondrocytes. Osteoarthritis Cartilage (2009) 1.16
Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med (2003) 3.07
Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis. Arthritis Res Ther (2009) 1.56
Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro. Biochem Pharmacol (2007) 1.51
Glycosaminoglycan polymerization may enable osmotically inactive Na+ storage in the skin. Am J Physiol Heart Circ Physiol (2004) 1.36
Electron microscopic findings in BAL of a fire-eater after petroleum aspiration. Chest (2003) 1.29
IGF-1 and PDGF-bb suppress IL-1β-induced cartilage degradation through down-regulation of NF-κB signaling: involvement of Src/PI-3K/AKT pathway. PLoS One (2011) 1.27
Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain. J Clin Invest (2008) 1.27
Curcumin mediated suppression of nuclear factor-κB promotes chondrogenic differentiation of mesenchymal stem cells in a high-density co-culture microenvironment. Arthritis Res Ther (2010) 1.23
Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathy. Circulation (2008) 1.17
Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem (2011) 1.15
In utero and lactational exposures to low doses of polybrominated diphenyl ether-47 alter the reproductive system and thyroid gland of female rat offspring. Environ Health Perspect (2008) 1.12
Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology (2003) 1.10
Resveratrol modulates interleukin-1β-induced phosphatidylinositol 3-kinase and nuclear factor κB signaling pathways in human tenocytes. J Biol Chem (2012) 1.10
Mesenchymal stem cells in regenerative medicine: opportunities and challenges for articular cartilage and intervertebral disc tissue engineering. J Cell Physiol (2010) 1.09
Osteoarthritis and obesity: experimental models. Joint Bone Spine (2008) 1.07
New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage (2005) 1.06
Loss of chondrogenic potential in dedifferentiated chondrocytes correlates with deficient Shc-Erk interaction and apoptosis. Osteoarthritis Cartilage (2004) 1.06
Apoptosis and the loss of chondrocyte survival signals contribute to articular cartilage degradation in osteoarthritis. Vet J (2003) 1.04
Interleukin-1beta-induced extracellular matrix degradation and glycosaminoglycan release is inhibited by curcumin in an explant model of cartilage inflammation. Ann N Y Acad Sci (2009) 1.04
Ultrastructural changes observed in rat ovaries following in utero and lactational exposure to low doses of a polybrominated flame retardant. Toxicol Lett (2005) 1.03
Simulated microgravity alters differentiation and increases apoptosis in human follicular thyroid carcinoma cells. FASEB J (2002) 0.99
Gene expression pattern of cells from inflamed and normal areas of osteoarthritis synovial membrane. Arthritis Rheumatol (2014) 0.99
Effects of curcumin (diferuloylmethane) on nuclear factor kappaB signaling in interleukin-1beta-stimulated chondrocytes. Ann N Y Acad Sci (2004) 0.98
Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cells. Toxicology (2005) 0.97
Sirt-1 is required for the inhibition of apoptosis and inflammatory responses in human tenocytes. J Biol Chem (2012) 0.97
Simulated weightlessness changes the cytoskeleton and extracellular matrix proteins in papillary thyroid carcinoma cells. Cell Tissue Res (2006) 0.96
Three-dimensional high-density co-culture with primary tenocytes induces tenogenic differentiation in mesenchymal stem cells. J Orthop Res (2011) 0.95
Lycopene inhibits disease progression in patients with benign prostate hyperplasia. J Nutr (2008) 0.95
Runx2- and histone deacetylase 3-mediated repression is relieved in differentiating human osteoblast cells to allow high bone sialoprotein expression. J Biol Chem (2007) 0.95
Accelerated mitochondrial adenosine diphosphate/adenosine triphosphate transport improves hypertension-induced heart disease. Circulation (2007) 0.95
Facilitative glucose transporters in articular chondrocytes. Expression, distribution and functional regulation of GLUT isoforms by hypoxia, hypoxia mimetics, growth factors and pro-inflammatory cytokines. Adv Anat Embryol Cell Biol (2008) 0.94
Osteochondral plate angiogenesis: a new treatment target in osteoarthritis. Joint Bone Spine (2010) 0.94
The importance of beta-carotene as a source of vitamin A with special regard to pregnant and breastfeeding women. Eur J Nutr (2007) 0.92
Synergistic effects of dexamethasone and quinolones on human-derived tendon cells. Int J Antimicrob Agents (2010) 0.92
Nutraceutical therapies for degenerative joint diseases: a critical review. Crit Rev Food Sci Nutr (2005) 0.92
Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: An open-label observational prospective study. J Orthop Res (2011) 0.92
High expression of PGE2 enzymatic pathways in cervical (pre)neoplastic lesions and functional consequences for antigen-presenting cells. Cancer Immunol Immunother (2008) 0.92
Early onset of chondroitin sulfate and osteopontin expression in angiotensin II-dependent left ventricular hypertrophy. Am J Hypertens (2002) 0.91
Expression of aquaporin 1 (AQP1) in human synovitis. Ann Anat (2010) 0.90
Increase of fibronectin and osteopontin in porcine hearts following ischemia and reperfusion. J Mol Med (Berl) (2005) 0.90
Application for proteomic techniques in studying osteoarthritis: a review. Front Physiol (2011) 0.90
Midkine acts as proangiogenic cytokine in hypoxia-induced angiogenesis. Am J Physiol Heart Circ Physiol (2012) 0.89
Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells. Ann Thorac Surg (2006) 0.87
Effects of the Des-F(6)-quinolone garenoxacin (BMS-284756), in comparison to those of ciprofloxacin and ofloxacin, on joint cartilage in immature rats. Antimicrob Agents Chemother (2002) 0.87
Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate. Arthritis Res Ther (2012) 0.86
Photoprotection of UV-irradiated human skin: an antioxidative combination of vitamins E and C, carotenoids, selenium and proanthocyanidins. Skin Pharmacol Appl Skin Physiol (2002) 0.85
Relationship between biochemical markers and radiographic scores in the evaluation of the osteoarticular status of Warmblood stallions. Res Vet Sci (2009) 0.85
Rab7 silencing prevents μ-opioid receptor lysosomal targeting and rescues opioid responsiveness to strengthen diabetic neuropathic pain therapy. Diabetes (2012) 0.84
Anabolic actions of IGF-I and TGF-beta1 on Interleukin-1beta-treated human articular chondrocytes: evaluation in two and three dimensional cultures. Histol Histopathol (2009) 0.84
Use of human umbilical cord blood-derived progenitor cells for tissue-engineered heart valves. Ann Thorac Surg (2010) 0.84
The transmembrane domains of L-selectin and CD44 regulate receptor cell surface positioning and leukocyte adhesion under flow. J Biol Chem (2010) 0.84
Regulation of 2-deoxy-D-glucose transport, lactate metabolism, and MMP-2 secretion by the hypoxia mimetic cobalt chloride in articular chondrocytes. Ann N Y Acad Sci (2006) 0.84
New perspectives in the management of osteoarthritis. structure modification: facts or fantasy? J Rheumatol Suppl (2003) 0.83
Body mass index and bioelectrical impedance phase angle as potentially modifiable nutritional markers are independent risk factors for outcome in allogeneic hematopoietic cell transplantation. Ann Hematol (2012) 0.83
Effects of 2,3,7,8-tetrachloro-dibenzo-p-dioxin on the extracellular matrix of the thymus in juvenile marmosets (Callithrix jacchus). Toxicology (2006) 0.83
Weightlessness induced apoptosis in normal thyroid cells and papillary thyroid carcinoma cells via extrinsic and intrinsic pathways. Endocrinology (2003) 0.82
Low doses of 2,3,7,8-tetrachlorodibenzo- p-dioxin increase transforming growth factor beta and cause myocardial fibrosis in marmosets ( Callithrix jacchus). Arch Toxicol (2002) 0.82
Influence of time, activities, and memory on the assessment of chronic low back pain intensity. Spine (Phila Pa 1976) (2009) 0.81
Polymethoxylated flavones, flavanone glycosides, carotenoids, and antioxidants in different cultivation types of tangerines ( Citrus reticulata Blanco cv. Sainampueng) from Northern Thailand. J Agric Food Chem (2010) 0.80
Osteogenic effects of resveratrol in vitro: potential for the prevention and treatment of osteoporosis. Ann N Y Acad Sci (2013) 0.80
Vascular endothelial growth factor inhibits programmed cell death of endothelial cells induced by clinorotation. J Gravit Physiol (2004) 0.80
Is volition the missing link in the management of low back pain? Joint Bone Spine (2010) 0.80
Reduced number, G protein coupling, and antinociceptive efficacy of spinal mu-opioid receptors in diabetic rats are reversed by nerve growth factor. J Pain (2013) 0.80
Effects of simulated microgravity on thyroid carcinoma cells. J Gravit Physiol (2002) 0.80
The L1 major capsid protein of HPV16 differentially modulates APC trafficking according to the vaccination or natural infection context. Eur J Immunol (2010) 0.80
Short-term culture of human neonatal myofibroblasts seeded using a novel three-dimensional rotary seeding device. ASAIO J (2006) 0.79
Bacterial lipopolysaccharides form procollagen-endotoxin complexes that trigger cartilage inflammation and degeneration: implications for the development of rheumatoid arthritis. Arthritis Res Ther (2013) 0.79
Evidence that TNF-β (lymphotoxin α) can activate the inflammatory environment in human chondrocytes. Arthritis Res Ther (2013) 0.79
Intraluminal application of vascular endothelial growth factor enhances healing of microvascular anastomosis in a rat model. J Vasc Res (2005) 0.79
[Effect of a Harpagophytum procumbens DC extract on matrix metalloproteinases in human chondrocytes in vitro]. Arzneimittelforschung (2004) 0.79
In vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin models. Arch Dermatol Res (2005) 0.79
Longterm conditions of mimicked weightlessness influences the cytoskeleton in thyroid cells. J Gravit Physiol (2004) 0.79
A hypothesis for the origin and pathogenesis of rheumatoid diseases. Rheumatol Int (2005) 0.78
Identification, validation and qualification of biomarkers for osteoarthritis in humans and companion animals: mission for the next decade. Vet J (2010) 0.78
Role of antioxidants in buccal mucosa cells and plasma on the incidence and severity of oral mucositis after allogeneic haematopoietic cell transplantation. Support Care Cancer (2011) 0.78
Effects of glucocorticoids on the respiratory burst of Chlamydia-primed THP-1 cells. Biochem Biophys Res Commun (2004) 0.78
Development and validation of a questionnaire assessing volitional competencies to enhance the performance of physical activities in chronic low back pain patients. BMC Musculoskelet Disord (2011) 0.78
Simulated microgravity induces programmed cell death in human thyroid carcinoma cells. J Gravit Physiol (2002) 0.78
Naturocetic (glucosamine and chondroitin sulfate) compounds as structure-modifying drugs in the treatment of osteoarthritis. Curr Opin Rheumatol (2003) 0.78
Current concepts in the therapeutic management of osteoarthritis with glucosamine. Bull Hosp Jt Dis (2005) 0.77
Effects of mycophenolic acid alone and in combination with its metabolite mycophenolic acid glucuronide on rat embryos in vitro. Arch Toxicol (2012) 0.77
Strontium ranelate (Fujisawa/Servier). Curr Opin Investig Drugs (2005) 0.77
Possible protective effects of alpha-tocopherol on enhanced induction of reactive oxygen species by 2-methoxyestradiol in tumors. Adv Exp Med Biol (2005) 0.77
Protein kinase C-mediated mu-opioid receptor phosphorylation and desensitization in rats, and its prevention during early diabetes. Pain (2016) 0.76
Coll2-1, Coll2-1NO2 and myeloperoxidase concentrations in the synovial fluid of equine tarsocrural joints affected with osteochondrosis. Vet Res Commun (2011) 0.76
Large scale expansion of human umbilical cord cells in a rotating bed system bioreactor for cardiovascular tissue engineering applications. Open Biomed Eng J (2013) 0.76
Increase in type II collagen turnover after iron depletion in patients with hereditary haemochromatosis. Rheumatology (Oxford) (2010) 0.76
OARSI recommendations on knee and hip osteoarthritis: use with discernment. Joint Bone Spine (2009) 0.75
Effects of moxifloxacin and clinafloxacin on murine limb buds cultured in regular and in magnesium-deficient medium. Arch Toxicol (2009) 0.75
Course of serum 25-hydroxyvitamin D(3) status and its influencing factors in adults undergoing allogeneic hematopoietic cell transplantation. Ann Hematol (2011) 0.75
Information for patients with low back pain: from research to clinical practice. Joint Bone Spine (2009) 0.75
Ecological or recalled assessments in chronic musculoskeletal pain? A comparative study of prospective and recalled pain assessments in low back pain and lower limb painful osteoarthritis. Pain Med (2011) 0.75